Flash News

TREE NEWS update: Xingyun Technology said its wholly owned overseas subsidiary SYNCLOUD INTERNATIONAL PTE. LTD. has completed delivery and acceptance of computing servers under a framework international trade sales agreement and sales orders signed with a client identified as VG. The two sales orders total about RMB573 million, and the company said the deal will have a certain impact on this year’s operating results.

TREE NEWS update: Jiangbolong Vice General Manager Zhu Yu sold 598,400 shares between September 22 and September 29, completing the disclosed reduction plan before its deadline expired. The Shenzhen-listed memory chip maker said the share disposal plan has now reached the end of its term and been fully implemented.

TREE NEWS reports: US spot crypto ETF inflows fell about 80% from Friday, with Bitcoin, Ether, Solana and XRP funds attracting $64.8 million combined on Monday. The pullback follows a week in which the funds took in roughly $3.3 billion, while the multi-day inflow streaks in the products remained intact.

TREE NEWS reports: Blockchain.com is reportedly preparing a $500 million IPO at a valuation of $4 billion to $6 billion and is telling prospective investors it aims to list this year. The wallet and exchange company filed confidentially with the SEC in May.

TREE NEWS update: Jabil (NYSE: JBL) will release fourth-quarter and full-year fiscal 2026 results before US market open on September 30, 2026, followed by a call positioned as its annual investor briefing on fiscal 2027 priorities. Management guided Q4 revenue of $9.2bn-$10bn and core EPS of $3.80-$4.20, with consensus near $4.05 and $9.61bn. Jabil expects about $13.6bn in AI-related revenue for fiscal 2026, roughly 50% above fiscal 2025’s $9bn.

TREE NEWS update: Dizal Pharmaceutical said it has received a $600 million upfront payment from AstraZeneca under a licensing agreement signed on July 14, 2026. The deal grants AstraZeneca exclusive global rights to develop and commercialize sunvozertinib, and took effect on August 31, 2026.

TREE NEWS reports: HSBC strategists said the decline in US equity valuations reflects pressure from the sharp rise in interest rates over recent months, while weak market breadth is typically a contrarian indicator pointing to oversold conditions. The team led by Max Kettner reiterated its bullish view on US stocks, citing improving economic growth and earnings expectations.

TREE NEWS update: Meta launched Muse, a personal AI agent that can browse the web, fill forms, compare prices across platforms and complete payments, on September 8. The product is Meta’s first attempt to connect its AI spending to a consumer and transaction business beyond advertising. Meta’s second-quarter revenue reached $60.8 billion, with advertising at $59.3 billion, while capital expenditure guidance for the year was set at $130-145 billion.

TREE NEWS update: Shandong Gold announced it plans to repurchase its A-shares for between RMB 300 million and RMB 400 million. The buyback covers a range of 3 billion to 4 billion yuan inclusive. No further terms, timing or funding source were specified in the filing.

TREE NEWS update: GigaDevice (兆易创新) bought back 390,000 of its A-shares on September 29, spending 141 million yuan. The repurchase is the latest in the Chinese chipmaker’s share buyback program. No further terms were disclosed.

TREE NEWS reports: Hong Kong stocks closed lower, with the Hang Seng Index down 0.48% and the Hang Seng Tech Index down 1.08%. Automakers led the decline, as Geely Automobile dropped more than 7%, while property developers gained, with China Vanke up over 11% and Greentown China up nearly 10%.

TREE NEWS reports: US memory-chip stocks rose modestly in premarket trading, with Micron Technology up 1.6% and SK Hynix and SanDisk each gaining 1.4%. The move came ahead of the opening bell on Wall Street.

TREE NEWS update: Summit Therapeutics shares rose more than 20% in US pre-market trading after AstraZeneca took a $2 billion stake in the company. The investment signals AstraZeneca’s confidence in ivonescimab, the drug developed by China’s Akeso that Summit licenses. The pre-market move followed disclosure of the $2 billion stake.

TREE NEWS reports: Anthropic’s 261-page IPO prospectus shows 2025 revenue rose 12-fold to $4.59 billion, up 1088% year over year, while operating losses exceeded $8 billion and GAAP net loss widened to $41.97 billion. The company targets a listing valuation above $2 trillion, more than double the $965 billion estimated in May, with the IPO possibly delayed until after November’s US midterm elections. Anthropic also committed $518 billion in future spending on cloud, compute and infrastructure.

TREE NEWS reports: China’s three main A-share indexes closed slightly higher on the day, with the Shanghai Composite up 0.18%, the Shenzhen Component up 0.34% and the ChiNext up 0.09%. Roughly 3,500 stocks across the Shanghai, Shenzhen and Beijing exchanges advanced, while combined turnover reached 1.42 trillion yuan. Real estate, battery, PCB and media sectors led gains, with Vanke A and several developers hitting the daily limit up; coal, oil and gas, agriculture and shipping lagged.

TREE NEWS reports: European equities opened mixed on the latest session, with the Euro Stoxx 50 up 0.27% and the UK’s FTSE 100 adding 0.19%. France’s CAC 40 rose 0.06%, while Germany’s DAX slipped 0.13% at the open.

TREE NEWS reports: China’s benchmark Shanghai Composite Index closed 0.18% higher at 3,830.45, while the Shenzhen Component rose 0.34% to 12,901.95 and the ChiNext Index added 0.09% to 3,142.56. The CSI 300 gained 0.10% to 4,345.21, the STAR 50 climbed 0.86% to 1,569.34, and the CSI 500 and CSI 1000 advanced 0.50% and 0.43% to 7,439.63 and 7,325.35.

TREE NEWS update: Faraday Future founder and global CEO YT Jia announced that the company’s robotics business will be folded into Nasdaq-listed AIxC and list separately at a $200 million valuation. The move aims to accelerate development of embodied-intelligence robots. No timeline or transaction terms were disclosed.

TREE NEWS reports: Japan’s Nikkei 225 closed 0.6% lower at 65,481.27, while the broader TOPIX index dropped 1.7% to 4,041.13. South Korea’s KOSPI also ended the session down 0.27% at 6,870.81. The declines mark a weaker close across major Asian equity benchmarks.

TREE NEWS update: Shanghai RAAS Biotech’s deputy chairman and general manager Xu Jun said on September 28 that the company’s proposed acquisition of Boehringer Ingelheim Biopharmaceuticals (China) is a strategic move to build out commercialization capacity for innovative drugs. Xu said the R&D push will be funded by steady cash flow from its blood products business on a rolling basis, and the company will not pour all blood-products profits into new drug development at once.